StockDuty ← Dashboard Nov 02, 2026 09:32 PM ET
SignalCorporate

Jazz Pharmaceuticals Non-GAAP EPS of -$3.88 misses by $1.50, revenue of $1.24B beats by $30M

Non-GAAP EPS miss of $1.50 offset by $30M revenue beat.

What changed
Non-GAAP EPS miss of $1.50 offset by $30M revenue beat.
Why it matters
Non-GAAP EPS miss of $1.50 offset by $30M revenue beat. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →